Viral myocarditis is a rare cardiac disease associated with the inflammation and injury of the myocardium. The downstream effects are a product of cooperation between viral processes and both the adaptive as innate host's immune response. Acute appearance of myocarditis is mostly idiopathic, i.e. of unknown origin. Primarily established on clinical observation and limited epidemiologic studies. Most studied cases are coxsackie, adeno and human immunodeficiency virus. Grey compartments describe extracellular matrix. Direct lines indicate downstream effects and dashed lines indicate speculative research.

Authors

Olivier Traets , Friederike Ehrhart , Egon Willighagen , Kristina Hanspers , Marvin Martens , Eric Weitz , and Finterly Hu

Cited In

• 
• 

Are you planning to include this pathway in your next publication? See How to Cite and add a link here to your paper once it's online.

Organism

Homo sapiens

Communities

Diseases Rare Diseases

Annotations

Pathway Ontology: myocarditis pathway disease pathway cardiomyopathy pathway

Disease Ontology: viral infectious disease myocarditis

Cell Type Ontology: cardiac muscle cell

Participants

References

1. Bowles NE, Richardson PJ, Olsen EG, Archard LC. Detection of Coxsackie-B-virus-specific RNA sequences in myocardial biopsy samples from patients with myocarditis and dilated cardiomyopathy. Lancet. 1986 May 17;1(8490):1120–3. PubMed Europe PMC Scholia
2. Iizuka N, Kuge S, Nomoto A. Complete nucleotide sequence of the genome of coxsackievirus B1. Virology. 1987 Jan;156(1):64–73. PubMed Europe PMC Scholia
3. Zhang Y, Schneider RJ. Adenovirus inhibition of cell translation facilitates release of virus particles and enhances degradation of the cytokeratin network. J Virol. 1994 Apr;68(4):2544–55. PubMed Europe PMC Scholia
4. Barry WH. Mechanisms of immune-mediated myocyte injury. Circulation. 1994 May;89(5):2421–32. PubMed Europe PMC Scholia
5. Muckelbauer JK, Kremer M, Minor I, Diana G, Dutko FJ, Groarke J, et al. The structure of coxsackievirus B3 at 3.5 A resolution. Structure. 1995 Jul 15;3(7):653–67. PubMed Europe PMC Scholia
6. Huber M, Selinka HC, Kandolf R. Tyrosine phosphorylation events during coxsackievirus B3 replication. J Virol. 1997 Jan;71(1):595–600. PubMed Europe PMC Scholia
7. Bergelson JM, Cunningham JA, Droguett G, Kurt-Jones EA, Krithivas A, Hong JS, et al. Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science. 1997 Feb 28;275(5304):1320–3. PubMed Europe PMC Scholia
8. Liu X, Zou H, Slaughter C, Wang X. DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis. Cell. 1997 Apr 18;89(2):175–84. PubMed Europe PMC Scholia
9. Leiden JM. The genetics of dilated cardiomyopathy--emerging clues to the puzzle. N Engl J Med. 1997 Oct 9;337(15):1080–1. PubMed Europe PMC Scholia
10. Fentzke RC, Korcarz CE, Lang RM, Lin H, Leiden JM. Dilated cardiomyopathy in transgenic mice expressing a dominant-negative CREB transcription factor in the heart. J Clin Invest. 1998 Jun 1;101(11):2415–26. PubMed Europe PMC Scholia
11. Li H, Zhu H, Xu CJ, Yuan J. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell. 1998 Aug 21;94(4):491–501. PubMed Europe PMC Scholia
12. Barbaro G, Di Lorenzo G, Grisorio B, Barbarini G. Incidence of dilated cardiomyopathy and detection of HIV in myocardial cells of HIV-positive patients. Gruppo Italiano per lo Studio Cardiologico dei Pazienti Affetti da AIDS. N Engl J Med. 1998 Oct 15;339(16):1093–9. PubMed Europe PMC Scholia
13. Wang X, Bergelson JM. Coxsackievirus and adenovirus receptor cytoplasmic and transmembrane domains are not essential for coxsackievirus and adenovirus infection. J Virol. 1999 Mar;73(3):2559–62. PubMed Europe PMC Scholia
14. Huber M, Watson KA, Selinka HC, Carthy CM, Klingel K, McManus BM, et al. Cleavage of RasGAP and phosphorylation of mitogen-activated protein kinase in the course of coxsackievirus B3 replication. J Virol. 1999 May;73(5):3587–94. PubMed Europe PMC Scholia
15. Bewley MC, Springer K, Zhang YB, Freimuth P, Flanagan JM. Structural analysis of the mechanism of adenovirus binding to its human cellular receptor, CAR. Science. 1999 Nov 19;286(5444):1579–83. PubMed Europe PMC Scholia
16. Henke A, Launhardt H, Klement K, Stelzner A, Zell R, Munder T. Apoptosis in coxsackievirus B3-caused diseases: interaction between the capsid protein VP2 and the proapoptotic protein siva. J Virol. 2000 May;74(9):4284–90. PubMed Europe PMC Scholia
17. Seipelt J, Liebig HD, Sommergruber W, Gerner C, Kuechler E. 2A proteinase of human rhinovirus cleaves cytokeratin 8 in infected HeLa cells. J Biol Chem. 2000 Jun 30;275(26):20084–9. PubMed Europe PMC Scholia
18. Badorff C, Lee GH, Knowlton KU. Enteroviral cardiomyopathy: bad news for the dystrophin-glycoprotein complex. Herz. 2000 May;25(3):227–32. PubMed Europe PMC Scholia
19. He Y, Chipman PR, Howitt J, Bator CM, Whitt MA, Baker TS, et al. Interaction of coxsackievirus B3 with the full length coxsackievirus-adenovirus receptor. Nat Struct Biol. 2001 Oct;8(10):874–8. PubMed Europe PMC Scholia
20. Liu QN, Reddy S, Sayre JW, Pop V, Graves MC, Fiala M. Essential role of HIV type 1-infected and cyclooxygenase 2-activated macrophages and T cells in HIV type 1 myocarditis. AIDS Res Hum Retroviruses. 2001 Oct 10;17(15):1423–33. PubMed Europe PMC Scholia
21. Barbaro G, Lipshultz SE. Pathogenesis of HIV-associated cardiomyopathy. Ann N Y Acad Sci. 2001 Nov;946:57–81. PubMed Europe PMC Scholia
22. Wu X, Deng Y. Bax and BH3-domain-only proteins in p53-mediated apoptosis. Front Biosci. 2002 Jan 1;7:d151-6. PubMed Europe PMC Scholia
23. Twu C, Liu NQ, Popik W, Bukrinsky M, Sayre J, Roberts J, et al. Cardiomyocytes undergo apoptosis in human immunodeficiency virus cardiomyopathy through mitochondrion- and death receptor-controlled pathways. Proc Natl Acad Sci U S A. 2002 Oct 29;99(22):14386–91. PubMed Europe PMC Scholia
24. Calandria C, Irurzun A, Barco A, Carrasco L. Individual expression of poliovirus 2Apro and 3Cpro induces activation of caspase-3 and PARP cleavage in HeLa cells. Virus Res. 2004 Aug;104(1):39–49. PubMed Europe PMC Scholia
25. Fiala M, Popik W, Qiao J-H, Lossinsky AS, Alce T, Tran K, et al. HIV-1 induces cardiomyopathyby cardiomyocyte invasion and gp120, Tat, and cytokine apoptotic signaling. Cardiovasc Toxicol. 2004;4(2):97–107. PubMed Europe PMC Scholia
26. Afanasyeva M, Georgakopoulos D, Rose NR. Autoimmune myocarditis: cellular mediators of cardiac dysfunction. Autoimmun Rev. 2004 Nov;3(7–8):476–86. PubMed Europe PMC Scholia
27. Holcik M, Sonenberg N. Translational control in stress and apoptosis. Nat Rev Mol Cell Biol. 2005 Apr;6(4):318–27. PubMed Europe PMC Scholia
28. Marash L, Kimchi A. DAP5 and IRES-mediated translation during programmed cell death. Cell Death Differ. 2005 Jun;12(6):554–62. PubMed Europe PMC Scholia
29. Barbaro G. HIV-associated cardiomyopathy etiopathogenesis and clinical aspects. Herz. 2005 Sep;30(6):486–92. PubMed Europe PMC Scholia
30. Yu S-W, Andrabi SA, Wang H, Kim NS, Poirier GG, Dawson TM, et al. Apoptosis-inducing factor mediates poly(ADP-ribose) (PAR) polymer-induced cell death. Proc Natl Acad Sci U S A. 2006 Nov 28;103(48):18314–9. PubMed Europe PMC Scholia
31. Chau DHW, Yuan J, Zhang H, Cheung P, Lim T, Liu Z, et al. Coxsackievirus B3 proteases 2A and 3C induce apoptotic cell death through mitochondrial injury and cleavage of eIF4GI but not DAP5/p97/NAT1. Apoptosis. 2007 Mar;12(3):513–24. PubMed Europe PMC Scholia
32. Esfandiarei M, McManus BM. Molecular biology and pathogenesis of viral myocarditis. Annu Rev Pathol. 2008;3:127–55. PubMed Europe PMC Scholia
33. Knowlton KU. CVB infection and mechanisms of viral cardiomyopathy. Curr Top Microbiol Immunol. 2008;323:315–35. PubMed Europe PMC Scholia
34. Sabbah A, Chang TH, Harnack R, Frohlich V, Tominaga K, Dube PH, et al. Activation of innate immune antiviral responses by Nod2. Nat Immunol. 2009 Oct;10(10):1073–80. PubMed Europe PMC Scholia
35. Blyszczuk P, Kania G, Dieterle T, Marty RR, Valaperti A, Berthonneche C, et al. Myeloid differentiation factor-88/interleukin-1 signaling controls cardiac fibrosis and heart failure progression in inflammatory dilated cardiomyopathy. Circ Res. 2009 Oct 23;105(9):912–20. PubMed Europe PMC Scholia
36. Kania G, Blyszczuk P, Eriksson U. Mechanisms of cardiac fibrosis in inflammatory heart disease. Trends Cardiovasc Med. 2009 Nov;19(8):247–52. PubMed Europe PMC Scholia
37. Vařecha M, Potěšilová M, Matula P, Kozubek M. Endonuclease G interacts with histone H2B and DNA topoisomerase II alpha during apoptosis. Mol Cell Biochem. 2012 Apr;363(1–2):301–7. PubMed Europe PMC Scholia
38. Sutterwala FS, Haasken S, Cassel SL. Mechanism of NLRP3 inflammasome activation. Ann N Y Acad Sci. 2014 Jun;1319(1):82–95. PubMed Europe PMC Scholia
39. Tschöpe C, Müller I, Xia Y, Savvatis K, Pappritz K, Pinkert S, et al. NOD2 (Nucleotide-Binding Oligomerization Domain 2) Is a Major Pathogenic Mediator of Coxsackievirus B3-Induced Myocarditis. Circ Heart Fail. 2017 Sep;10(9):e003870. PubMed Europe PMC Scholia